VANI ▼ -0.9% - Vivani Medical, Inc. $VANI - Vivani Medical Announces Positive Top-Line Results from SLIM-1™, a First in Human Phase 1 Trial of NPM-139 (semaglutide implant) and Wegovy (weekly semaglutide injections) in Obese and Overweight Subjects 12-NOV-2026 08:00 AM ET